- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04956497
Registry Study of Extracorporeal Cardiopulmonary Resuscitation (eCPR) in China (ECPR-China)
July 8, 2021 updated by: Peking Union Medical College Hospital
The data of patients undergo extracorporeal cardiopulmonary resuscitation (eCPR) will be collected and analyzed.
This study will provide useful information about the indication, the start time and others to improve the outcome of ECPR.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
300
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jun Xu, MD
- Phone Number: 15801578819
- Email: xunjunfree@126.com
Study Locations
-
-
-
Beijing, China, 100730
- Peking Union Medical College Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All adult (age>=18y) cardiac arrested patients accept ECPR treatment will be enrolled in the study.
Description
Inclusion Criteria:
- Age >=18y
- Cardiac arrested patients accept ECPR treatment
Exclusion Criteria:
- No
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
mortality rate
Time Frame: 28 days
|
the death rate of the patients
|
28 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Jun Xu, MD, Peking Union Medical College Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
September 1, 2021
Primary Completion (Anticipated)
October 31, 2023
Study Completion (Anticipated)
December 31, 2023
Study Registration Dates
First Submitted
July 8, 2021
First Submitted That Met QC Criteria
July 8, 2021
First Posted (Actual)
July 9, 2021
Study Record Updates
Last Update Posted (Actual)
July 9, 2021
Last Update Submitted That Met QC Criteria
July 8, 2021
Last Verified
May 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PUMCH-001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Extracorporeal Membrane Oxygenation Complication
-
UMC UtrechtErasmus Medical Center; Catharina Ziekenhuis Eindhoven; St. Antonius Hospital; Leiden... and other collaboratorsRecruitingExtracorporeal Membrane Oxygenation | Extracorporeal Membrane Oxygenation ComplicationNetherlands
-
Sydney Local Health DistrictNot yet recruitingExtracorporeal Membrane Oxygenation ComplicationAustralia
-
Eurosets S.r.l.RecruitingExtracorporeal Membrane Oxygenation ComplicationAustria
-
Australian and New Zealand Intensive Care Research...National Health and Medical Research Council, Australia; Monash UniversityRecruitingExtracorporeal Membrane Oxygenation ComplicationAustralia
-
Second Affiliated Hospital, School of Medicine,...The Second Affiliated Hospital of Jiaxing University; Changxing People's Hospital and other collaboratorsRecruitingExtracorporeal Membrane Oxygenation ComplicationChina
-
University Hospital, ToulouseUnknownExtracorporeal Membrane Oxygenation ComplicationFrance
-
Xiaotong HouNot yet recruitingExtracorporeal Membrane Oxygenation ComplicationChina
-
Vanderbilt University Medical CenterRecruiting
-
Renzo Loyaga RendonSpectrum Health Hospitals; Van Andel Research InstituteActive, not recruiting
-
Xiaotong HouNot yet recruitingExtracorporeal Membrane Oxygenation ComplicationChina
Clinical Trials on extracorporeal membrane oxygenation (ECMO)
-
Second Affiliated Hospital of Guangzhou Medical...RecruitingSeptic Shock | Extracorporeal Membrane Oxygenation | Cardiogenic Shock | Septic CardiomyopathyChina
-
Rennes University HospitalCompletedExtraCorporeal Membrane OxygenationFrance
-
Barts & The London NHS TrustStryker Nordic; London's Air Ambulance; Bodychillz Ltd; Maquet Cardiopulmonary...UnknownVentricular Fibrillation | Cardiopulmonary Arrest With Successful Resuscitation | Death, Sudden, Cardiac | Out-Of-Hospital Cardiac ArrestUnited Kingdom
-
Massachusetts General HospitalWithdrawnCardiac Arrest | Pulmonary InjuryUnited States
-
Erasmus Medical CenterCompletedCardiac Arrest | Extracorporeal Cardiopulmonary ResuscitationNetherlands
-
Imam Abdulrahman Bin Faisal UniversityKing Abdulaziz University; Ministry of Health, Saudi ArabiaCompletedRefractory Hypoxemia | MERS-CoV InfectionSaudi Arabia
-
University of MinnesotaTerminatedVentricular Fibrillation | Cardiac Arrest | Out-Of-Hospital Cardiac Arrest | Extracorporeal Membrane Oxygenation Complication | Pulseless Ventricular TachycardiaUnited States
-
China-Japan Friendship HospitalUnknownExtracorporeal Membrane Oxygenation | PharmacokineticsChina
-
University of CambridgeGuy's and St Thomas' NHS Foundation Trust; Manchester University NHS Foundation... and other collaboratorsCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedLung Diseases | Acute Respiratory Failure